Evommune (EVMN) Change in Account Payables (2024 - 2026)
Evommune (EVMN) reported Change in Account Payables of -$3.7 million for Q1 2026, down 442.55% year-over-year from $1.1 million in Q1 2025, and down 197.35% quarter-over-quarter from $3.9 million in Q4 2025.
Evommune (EVMN) Change in Account Payables (2024 - 2026) Analysis & Trends
Evommune (EVMN) has 3 years of Change in Account Payables data on file, last reported at -$3.7 million in Q1 2026.
- Change in Account Payables for Q1 2026 came in at -$3.7 million, down 442.55% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.3 million (changed N/A YoY), and the FY2025 annual result was -$837000.0, down 112.87% from the prior year.
- Change in Account Payables declined to -$3.7 million in Q1 2026 per EVMN's latest filing, from $3.9 million in the prior quarter.
- Over five years, Change in Account Payables peaked at $3.9 million in Q4 2025 and troughed at -$3.7 million in Q1 2026.
- A 3-year average of $566250.0 and a median of $1.1 million in 2024 frame the typical range for Change in Account Payables.
- The sharpest annual moves came in 2025 and 2026: Change in Account Payables soared 34.93% in 2025, then tumbled 442.55% in 2026.
- A 3-year view of Change in Account Payables shows it stood at $2.9 million in 2024, then jumped by 34.93% to $3.9 million in 2025, then sank by 197.35% to -$3.7 million in 2026.
- Business Quant data shows EVMN's Change in Account Payables at -$3.7 million in Q1 2026, $3.9 million in Q4 2025, and -$691000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -3.26 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 35.60 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -9.42 Mn |
| 10 | Evommune | 695.29 Mn | 483.82 Mn | - | -3.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.75 Mn |
| Mar 31, 2026 | -3.75 Mn |
| Dec 31, 2025 | 3.85 Mn |
| Dec 31, 2025 | 3.85 Mn |
| Mar 31, 2025 | -691,000.00 |
| Mar 31, 2025 | -691,000.00 |
| Dec 31, 2024 | 2.85 Mn |
| Dec 31, 2024 | 2.85 Mn |